Shopping Cart
Remove All
Your shopping cart is currently empty
PD 404182 is a human dimethylarginine dimethylaminohydrolase 1 (DDAH1) inhibitor with anti-angiogenic and antiviral activities, and can be used to study cardiovascular diseases and viral infections.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $32 | - | In Stock | |
| 5 mg | $75 | 7-10 days | 7-10 days | |
| 10 mg | $113 | 7-10 days | 7-10 days | |
| 25 mg | $228 | 7-10 days | 7-10 days | |
| 50 mg | $372 | 7-10 days | 7-10 days | |
| 100 mg | $548 | 7-10 days | 7-10 days | |
| 1 mL x 10 mM (in DMSO) | $80 | 7-10 days | 7-10 days |
| Description | PD 404182 is a human dimethylarginine dimethylaminohydrolase 1 (DDAH1) inhibitor with anti-angiogenic and antiviral activities, and can be used to study cardiovascular diseases and viral infections. |
| Targets&IC50 | PBMC cells (human):200 μM (CC50), DDAH1 (human):9 μM, HIV-1 (92UG029):1.18 μM, HIV-1 (96USNG31):0.14 μM |
| In vitro | The enzymatic activity of human DDAH1 was significantly and dose-dependently inhibited by PD 404182, with an IC50 = 9 μM. [1] PD 404182 exhibited antiviral activity toward all the viral isolates tested, with an average IC50 of 0.55 μM (IC50 range, 0.14 μM with HIV-1 96USNG31 to 1.18 μM with HIV-1 92UG029). A 48% reduction in cell viability was observed at the highest tested PD 404182 concentration (200 μM), resulting in a CC50 of ∼200 μM, indicating that PD 404182 is relatively nontoxic to freshly activated human PBMCs. [2] |
| Synonyms | PD-404182, PD404182 |
| Molecular Weight | 217.29 |
| Formula | C11H11N3S |
| Cas No. | 72596-74-8 |
| Smiles | N=C1SC=2C=CC=CC2C3=NCCCN13 |
| Relative Density. | 1.43 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 40 mg/mL (184.09 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (9.2 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.